Key result
Breast cancer survivors in the first year posttreatment had higher heart rates and lower heart rate variability compared to healthy matched controls.
Why the study?
Does breast cancer survivorship in the first year posttreatment alter heart rate variability compared to healthy controls?
Case-Control (n=44)
Does breast cancer survivorship in the first year posttreatment alter heart rate variability compared to healthy controls?
Breast cancer survivors exhibit cardiovascular autonomic imbalance in the first year post-treatment, suggesting HRV could be a useful tool for early detection of cardiovascular disease in this population.
Answers are grounded in this paper and cite their sources.
May indicate early autonomic imbalance in breast cancer survivors; hypothesis-generating for HRV monitoring, pending prospective validation.
The same aggressive treatments that have led to a reduction in the breast cancer may also have adverse effects on cardiac autonomic balance. The objective of this study was to compare heart rate variability (HRV) between breast cancer survivors in the first year posttreatment and healthy women, controlling for known confounders. This descriptive case-controlled study included 22 breast cancer survivors and 22 healthy age- and sex-matched controls. Short-term HRV was measured using an accepted methodology to assess the cardiac autonomic balance. One-way analysis of covariance results revealed that heart rate was significantly higher (F = 15.86, p < .001) and the standard deviation of normal-to-normal (NN) interval (F = 19.93, p = .001), square root of mean squared differences of successive NN intervals (F = 18.72, p = .001), HRV index (F = 5.44, p = .025), and high-frequency (F = 5.77, p = .03) values were significantly lower in the breast cancer survivors than in the matched controls. The principal finding of the presence of a cardiovascular imbalance in breast cancer survivors in comparison to healthy age-matched controls suggests that HRV study could be a clinically useful tool to detect cardiovascular disease in early-stage breast cancer survivors.
No takes yet. Share an insight, caveat, or question.
Caro-Morán et al. (2015) conducted a case-control in Breast cancer (n=44). History of breast cancer treatments vs. Healthy age- and sex-matched controls was evaluated on Heart rate variability (HRV) (p=<.001). Breast cancer survivors in the first year posttreatment had higher heart rates and lower heart rate variability compared to healthy matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: